PPARβ/δ prevents inflammation and fibrosis during diabetic cardiomyopathy
Diabetic cardiomyopathy (DCM) is a specific type of myocardial disease that often develops in patients suffering from diabetes, which has become the foremost cause of death among them. It is an insidious multifactorial disease caused by complex and partially unknown mechanisms that include metabolic...
Saved in:
Main Authors: | Rostami, Adel, Palomer, Xavier, Pizarro-Delgado, Javier, Barroso, Emma, Valenzuela-Alcaraz, Brenda, Crispi, Fátima, Nistal, J. Francisco, Hurlé, María A., García, Raquel, Wahli, Walter, Vázquez-Carrera, Manuel |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2025
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/183670 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPARβ/δ attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells
by: Zhang, Meijian, et al.
Published: (2024) -
Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression
by: Sng, Ming Keat, et al.
Published: (2018) -
Subclinical Cardiomyopathy in Miyoshi Myopathy Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Imaging A Case for Routine Cardiac Screening?
by: Tan, Sarah Ming Li, et al.
Published: (2022) -
Diverse clinical spectrum of stress-induced cardiomyopathy
by: Lee, Y.-P., et al.
Published: (2015) -
Hereditary transthyretin amyloid cardiomyopathy
by: Zheng, Y, et al.
Published: (2023)